BenevolentAI, a leading clinical-stage AI-enabled drug discovery company, announces that AstraZeneca has selected an additional novel target for idiopathic pulmonary fibrosis (IPF) for its...
Antengene Corporation Limited, a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and oncology,...
German life science biotech firm, LenioBio GmbH, announced the generation of a novel plant glycan knockout cell line that will increase the versatility and...
Novo Holdings A/S, a leading international life sciences investor, announces that its portfolio company F2G Ltd. (F2G) has entered into a strategic collaboration with...
Atamyo Therapeutics, a biotechnology company focused on the development of new-generation gene therapies targeting neuromuscular diseases, announced multiple major milestones for ATA-100 and ATA-200,...
